Neuropace, Inc. NPCE Q1 2025 earnings
Reported May 13, 2025 · Before market open
Revenue estimate$22.7M
EPS estimate-$0.26
Next report
Aug 11, 2026 (In 4 weeks)Revenue estimate$22.6M
EPS estimate-$0.19
Financials
Q1 2025Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Ask the moment Neuropace, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Neuropace, Inc. report Q1 2025 earnings?
- Neuropace, Inc. (NPCE) reported Q1 2025 earnings on May 13, 2025 before market open.
- What were Neuropace, Inc.'s Q1 2025 revenue and EPS?
- Neuropace, Inc. reported revenue of $22.5M and diluted EPS of $-0.21 for Q1 2025.
- Did Neuropace, Inc. beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $22.7M by $186.3K. EPS beat the consensus estimate of $-0.26 by $0.05.
- How did Neuropace, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 24.3% from $18.1M a year earlier and diluted EPS grew 34.4% from $-0.32.
- Where can I find Neuropace, Inc.'s Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001528287-25-000013) directly on SEC EDGAR. The filing index links above go to sec.gov.